ADIM
PNTG icon

Alpha DNA Investment Management’s Pennant Group PNTG Stock Holding History

Alpha DNA Investment Management’s Portfolio PNTG Stock Details PNTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,728
Closed -$481K – 244
2024
Q2 		$481K Buy
+20,728
New +$454K 0.19% 115
2021
Q2 		– Sell
-23
Closed -$1K – 502
2021
Q1 		$1K Sell
23
-2
-8% -$110 ﹤0.01% 641
2020
Q4 		$1K Buy
+25
New +$1.2K ﹤0.01% 539

Other funds holding PNTG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CA
Crewe Advisors Salt Lake City, Utah $1.17B AUM 29.21% 1-Year Est. Return

Alpha DNA Investment Management's PNTG Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Pennant Group (PNTG) in Q3 2024, closing a stake of 20,728 shares — an estimated $481K sold.

Alpha DNA Investment Management first reported a position in PNTG in Q4 2020 and held it in 3 quarters. The position peaked at $481K in Q2 2024. 171 funds tracked by Wall St. Rank hold PNTG as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Pennant Group position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 20,728 Pennant Group shares in Q3 2024, an estimated $481K.
  • Alpha DNA Investment Management first reported a position in Pennant Group in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Pennant Group position peaked at $481K in Q2 2024.
  • 171 funds tracked by Wall St. Rank held Pennant Group as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.